carvedilol has been researched along with Shock in 2 studies
Shock: A pathological condition manifested by failure to perfuse or oxygenate vital organs.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Srivastava, S | 1 |
| Kemnic, T | 1 |
| Hildebrandt, KR | 1 |
| Christopher, TA | 1 |
| Lopez, BL | 1 |
| Yue, TL | 1 |
| Feuerstein, GZ | 1 |
| Ruffolo, RR | 1 |
| Ma, XL | 1 |
2 other studies available for carvedilol and Shock
| Article | Year |
|---|---|
BRASH syndrome.
Topics: Antihypertensive Agents; Atrioventricular Block; Bradycardia; Bumetanide; Carvedilol; Female; Humans | 2020 |
Carvedilol, a new beta-adrenoreceptor blocker, vasodilator and free-radical scavenger, exerts an anti-shock and endothelial protective effect in rat splanchnic ischemia and reperfusion.
Topics: Adrenergic beta-Antagonists; Animals; Carbazoles; Carvedilol; Endothelium, Vascular; Free Radical Sc | 1995 |